News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
27,001 Results
Type
Article (1341)
Company Profile (4)
Press Release (25656)
Section
Business (13001)
Career Advice (77)
Deals (1846)
Drug Delivery (4)
Drug Development (2114)
Employer Resources (2)
FDA (440)
Job Trends (664)
News (16774)
Policy (964)
Tag
Academia (35)
Allergies (2)
Alliances (906)
ALS (3)
Alzheimer's disease (41)
Antibody-drug conjugate (ADC) (7)
Approvals (464)
Artificial intelligence (10)
Autoimmune disease (3)
Bankruptcy (7)
Best Places to Work (573)
Biosimilars (2)
Biotechnology (1)
Bladder cancer (8)
Brain cancer (2)
Breast cancer (23)
Cancer (129)
Cardiovascular disease (16)
Career advice (55)
CAR-T (3)
Cell therapy (5)
Cervical cancer (1)
Clinical research (1892)
Collaboration (25)
Compensation (18)
Complete response letters (2)
COVID-19 (106)
CRISPR (2)
C-suite (7)
Cystic fibrosis (3)
Data (227)
Depression (1)
Diabetes (15)
Diagnostics (299)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (5)
Drug pricing (6)
Duchenne muscular dystrophy (3)
Earnings (12387)
Editorial (2)
Employer resources (2)
Events (2073)
Executive appointments (3)
FDA (633)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (28)
Gene editing (4)
Gene therapy (7)
GLP-1 (28)
Government (169)
Guidances (132)
Healthcare (697)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (5)
Indications (2)
Infectious disease (119)
Inflammatory bowel disease (7)
Influenza (2)
Intellectual property (2)
Interviews (10)
IPO (1368)
IRA (1)
Job creations (129)
Job search strategy (54)
JPM (2)
Labor market (5)
Layoffs (27)
Leadership (1)
Legal (199)
Liver cancer (1)
Lung cancer (21)
Lymphoma (16)
Management (1)
Manufacturing (10)
MASH (5)
Medical device (593)
Medtech (599)
Mergers & acquisitions (516)
Metabolic disorders (39)
mRNA (4)
Multiple sclerosis (1)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (1)
Neuroscience (64)
NextGen: Class of 2026 (137)
Non-profit (52)
Now hiring (2)
Obesity (20)
Opinion (7)
Ovarian cancer (1)
Pain (9)
Pancreatic cancer (4)
Parkinson's disease (7)
Partnered (2)
Patents (2)
Patient recruitment (7)
People (788)
Pharmaceutical (1)
Phase 1 (425)
Phase 2 (733)
Phase 3 (805)
Pipeline (578)
Policy (3)
Postmarket research (104)
Preclinical (189)
Press Release (1)
Prostate cancer (5)
Radiopharmaceuticals (6)
Rare diseases (10)
Real estate (136)
Regulatory (701)
Reports (2)
Research institute (41)
Resumes & cover letters (14)
Rett syndrome (1)
RNA editing (1)
RSV (5)
Schizophrenia (4)
Series A (5)
Series B (4)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (4)
Sponsored (2)
Startups (94)
Supply chain (3)
The Weekly (2)
Vaccines (36)
Venture capital (3)
Weight loss (17)
Women's health (3)
Worklife (1)
Date
Today (16)
Last 7 days (44)
Last 30 days (126)
Last 365 days (1457)
2026 (156)
2025 (1465)
2024 (1534)
2023 (1809)
2022 (2015)
2021 (2438)
2020 (1863)
2019 (1388)
2018 (1102)
2017 (831)
2016 (519)
2015 (819)
2014 (722)
2013 (302)
2012 (6446)
2011 (515)
2010 (533)
Location
Africa (24)
Alabama (1)
Arizona (6)
Asia (1884)
Australia (192)
California (448)
Canada (141)
China (29)
Colorado (25)
Connecticut (14)
Delaware (31)
Europe (3795)
Florida (71)
Georgia (19)
Idaho (2)
Illinois (40)
India (1)
Indiana (33)
Japan (24)
Kansas (2)
Kentucky (3)
Louisiana (7)
Maine (7)
Maryland (74)
Massachusetts (396)
Michigan (21)
Minnesota (33)
Missouri (4)
Montana (1)
Nevada (8)
New Hampshire (5)
New Jersey (175)
New York (141)
North Carolina (71)
Northern California (268)
Ohio (13)
Pennsylvania (117)
South America (41)
South Carolina (1)
Southern California (154)
Tennessee (6)
Texas (69)
United States (1878)
Utah (16)
Virginia (6)
Washington D.C. (2)
Washington State (43)
Wisconsin (5)
27,001 Results for "135".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
January 16, 2026
·
8 min read
Press Releases
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
January 16, 2026
·
8 min read
Press Releases
Jade Biosciences Announces $135 Million Private Placement
October 8, 2025
·
6 min read
Press Releases
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
January 8, 2026
·
7 min read
Press Releases
Akeso Unveils Promising Preclinical Data for IL-1RAP Targeting Antibody (AK135) at SITC 2025
November 10, 2025
·
5 min read
Press Releases
First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin
December 3, 2025
·
2 min read
Press Releases
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
September 24, 2025
·
5 min read
Deals
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem
Instead of homing in on PSMA—currently the most validated target in prostate cancer—BMS and Philochem will instead collaborate on an early-stage molecule that binds to a novel marker called ACP3.
June 11, 2025
·
2 min read
·
Tristan Manalac
Funding
SpliceBio Nabs $135 Million Series B To Advance Protein Splicing Medicines
The company’s intein-based technology is initially aimed at Stargardt disease, a type of macular degeneration.
June 11, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics
May 2, 2025
·
4 min read
1 of 2,701
Next
